Niva Bupa Share Price Target 2025 To 2030
Niva Bupa, a significant player in India’s health insurance sector, is poised to make waves with its upcoming IPO. Investors are keen to know more about the company’s growth potential and share price predictions for the coming years.
This article will look at Niva Bupa’s expected share price targets from 2024 to 2030, using both technical and fundamental analysis. We’ll cover the company’s financial trends, growth prospects, and other factors that might affect its future stock performance.
Table of Contents
- 1 Basic Details of Niva Bupa
- 2 Niva Bupa IPO GMP Today
- 3 Niva Bupa Share Price Target 2024
- 4 Niva Bupa Share Price Target 2025
- 5 Niva Bupa Share Price Target 2026
- 6 Niva Bupa Health Insurance Share Price Target 2027
- 7 Niva Bupa Share Price Target 2028
- 8 Niva Bupa Share Price Target 2029
- 9 Niva Bupa Share Price Target 2030
- 10 Technical and Fundamental Analysis of Niva Bupa
Basic Details of Niva Bupa
Company Name | Niva Bupa Health Insurance Company Ltd. |
Business Sector | Health Insurance |
Stock Symbol | — |
NSE Listing Status | — |
BSE Listing Status | — |
Official Website | https://www.nivabupa.com |
About Niva Bupa’s Business
Niva Bupa Health Insurance Company Ltd. is a prominent health insurance provider in India, offering a variety of insurance products that cater to families, individuals, and businesses. Known for its innovative products and robust customer support, the company has established itself as a trusted name in health insurance.
Niva Bupa focuses on providing affordable healthcare coverage, ensuring that its customers have access to high-quality medical services and financial security.
Niva Bupa IPO Details
Detail | Information |
---|---|
Mainboard | Yes |
Market Cap | Small Cap |
Industry | Insurance |
Investor Type | Retail, HNI |
Bid Price Range | ₹70.00 – ₹74.00 |
Lot Size | 200 Shares |
Retail Discount | ₹0.00 |
Issue Size | ₹2,200.00 Cr |
Offer Type | Mainboard |
IPO Type | Book Building |
Minimum Investment | ₹14,000.00 (1 Lot) |
Maximum Investment | ₹1,92,400.00 (13 Lots) |
Niva Bupa IPO Important Dates
Event | Date |
---|---|
Offer Starts | 7th Nov |
Offer Ends | 11th Nov |
Allotment Date | 12th Nov |
Listing Date | 14th Nov |
Niva Bupa IPO GMP Today
The grey market premium (GMP) for the Niva Bupa Health Insurance IPO is currently around ₹0. This indicates that there is limited immediate demand for the shares in the unofficial market, though this can change as the IPO progresses.
The IPO, which opened on November 7 and will close on November 11, 2024, is offered with a price band of ₹70-₹74 per share. It’s attracting a range of investors, but due to the lack of GMP premium, it suggests cautious market sentiment at present.
If you’re considering investing, it’s often advisable to look at both the company’s fundamentals and broader market trends rather than relying solely on the grey market indicators, as they can be volatile and are unofficial measures of demand.
In 2024, Niva Bupa’s first year on the stock market, investors are closely watching its performance post-IPO, anticipating a strong start due to its promising growth trajectory in the insurance sector.
Year | Low Approx | High Approx |
---|---|---|
2024 | ₹85 | ₹110 |
By 2025, Niva Bupa is expected to gain traction as it leverages its extensive reach and customer base, with further growth anticipated in its market share and financial results.
Year | Low Approx | High Approx |
---|---|---|
2025 | ₹115 | ₹135 |
In 2026, the company’s continued innovations and expansion efforts are likely to drive a rise in its share price, supported by solid revenue growth and increased asset value.
Year | Low Approx | High Approx |
---|---|---|
2026 | ₹140 | ₹165 |
By 2027, Niva Bupa’s expansion plans in India’s insurance landscape may yield higher valuation, with increased brand presence potentially pushing its share price to new levels.
Year | Low Approx | High Approx |
---|---|---|
2027 | ₹170 | ₹200 |
With a solidified position in the health insurance market by 2028, Niva Bupa is expected to showcase steady growth, with market confidence keeping the share price stable.
Year | Low Approx | High Approx |
---|---|---|
2028 | ₹205 | ₹235 |
Approaching the end of the decade, Niva Bupa’s strategies for sustainable growth are likely to reflect positively in its share price, attracting long-term investors.
Year | Low Approx | High Approx |
---|---|---|
2029 | ₹240 | ₹275 |
By 2030, Niva Bupa is expected to reach a strong market value, with more opportunities for growth and new, innovative health insurance solutions.
Year | Low Approx | High Approx |
---|---|---|
2030 | ₹280 | ₹320 |
Technical and Fundamental Analysis of Niva Bupa
To forecast Niva Bupa’s future growth, we need to examine its technical patterns and fundamental strength. By analyzing market sentiment and the company’s financial performance, we can gauge Niva Bupa’s potential trajectory over the next several years. so wait until listing and proper chart.
Financial Trend Analysis
(in Crores) | FY’22 | FY’23 | FY’24 |
---|---|---|---|
Total Income | 1,884 | 2,859 | 4,118 |
Profit After Tax (PAT) | 196 | 12 | 81 |
Total Assets | 2,738 | 3,876 | 6,191 |
Net Worth | 507 | 831 | 2,049 |
Borrowing | 250 | 250 | 250 |
Particulars | Pre-Issue | Post-Issue |
---|---|---|
Promoter | 88.99% | 73.38% |
Public | 11.01% | 26.62% |
Total | 100% | 100% |
Niva Bupa’s consistent growth in income and assets, alongside a steady increase in net worth, reflects a solid foundation for expansion.
Conclusion
Niva Bupa’s IPO presents an exciting opportunity as the company enters the stock market. As a trusted player in India’s health insurance sector, Niva Bupa shows strong growth potential backed by solid financials and an expanding customer base.
Projected share price targets suggest steady appreciation over the next several years, making it an appealing choice for both short- and long-term investors. However, as with any investment, it’s essential to consider market risks and personal risk tolerance. Niva Bupa could be a valuable addition for those seeking growth in the insurance sector.
The company is very competitive and well known for its aggressive marketing.